Skyscape Web Viewer : EBMG : Cardiovascular Disease and Vascular Diseases : Main Index

View All
Non-radiographic axial spondyloarthritis
Non-pharmacological interventions
Non-pharmacological treatment
Non-pregnant
Non-seasonal depression
Nonsmall cell lung cancer Palliative Radiotherapy Regimes for Non-Small Cell Lung Cancer Treatment of Lung Cancer Surgery for Early Stage Non-Small Cell Lung Cancer
Non-small-cell lung cancer
Nonspecific low back pain
Non-ST-elevation myocardial infarction Clopidogrel Plus Aspirin Versus Aspirin Alone for Preventing Cardiovascular Disease in Acute Non-ST Segment Coronary Syndromes Acute Coronary Syndrome and Myocardial Infarction - Related Resources Routine or Selective Invasive Strategy for Acute Coronary Syndrome
Non-Steroidal Anti-Inflammatory Agents Medical Prophylaxis and Treatment of Cystoid Macular Oedema after Cataract Surgery Nsaids Versus Opioids and Non-Opioids for Acute Renal Colic Treatment for Superficial Thrombophlebitis of the Leg Nsaids in Acute Renal Colic Oral Non-Steroidal Anti-Inflammatory Drugs for Lung Disease in Cystic Fibrosis
Nonsteroidal anti-inflammatory drugs
non-ST-segment elevation infarction Acute Coronary Syndrome and Myocardial Infarction - Related Resources Platelet Glycoprotein Iib/Iiia Receptor Antagonists in Cardiovascular Disease
non-ST segment elevation myocardial infarction Acute Coronary Syndrome and Myocardial Infarction Low Molecular Weight Heparins for Acute Coronary Syndromes
Non-surgical treatment
Non-ulcer dyspepsia
Nonunion Treatment of Tibial Shaft Fractures Treatment of Isolated Ulnar Fractures in Adults
Non-users Hormone Replacement Therapy and Risk of Venous Thromboembolism Nsaids and Risk of Acute Renal Failure Oral Contraceptives in Patients Who have Experienced One Venous Thrombosis Risk of Myocardial Infarction in Users of Third Generation Oral Contraceptives Third Generation Oral Contraceptives and Risk of Venous Thromboembolism Ischaemic Stroke and Myocardial Infarction Risk with Combined Oral Contraceptives Olanzapine and Risk of Diabetes Risk of Lactic Acidosis with Metformin in Type 2 Diabetes Risk of Venous Thromboembolism in Users of Combined Oral Contraceptives Transdermal and Oral Hormone Replacement Therapy and the Risk of Stroke
Non-valvular atrial fibrillation
Non-vertebral fracture Risedronate for the Prevention of Osteoporotic Fractures in Postmenopausal Women Raloxifene for the Prevention of Fractures in Postmenopausal Women
Non-vertebral fractures Bisphosphonates in Multiple Myeloma Effect of Calcitonin on Vertebral and other Fractures Strontium Ranelate for Preventing and Treating Postmenopausal Osteoporosis The Effect of Bisphosphonates on Skeletal Morbidity in Metastatic Cancer Alendronate for the Primary and Secondary Prevention of Osteoporotic Fractures in Postmenopausal Women Calcitonin for Corticosteroid-Induced Osteoporosis Risedronate for the Prevention of Osteoporotic Fractures in Postmenopausal Women Teriparatide for the Prevention of Fractures in Postmenopausal Women Vitamin D and Vitamin D Analogues with or Without Calcium Supplement for Preventing Fractures in Post-Menopausal Women and Older Men
non-vitamin K antagonist oral anticoaculants
No placebo Acetylcholinesterase Inhibitor Treatment for Myasthenia Gravis Cryotherapy for Genital Warts Antibiotics for Mastitis in Breastfeeding Women Interventions for Smokeless Tobacco Use Cessation
No probiotic therapy
No radiotherapy Radiotherapy and Surgery in Early Breast Cancer Longterm Neurocognitive Side Effects of Radiotherapy for Glioma
Norelgestromin Risk of Venous Thromboembolism in Users of Combined Oral Contraceptives Risk of Venous Thrombosis in Users of 3rd Vs. 2nd Generation Combined Oral Contraceptives
Norethindrone Biphasic Versus Monophasic Oral Contraceptives Combined Oral Contraceptive Pills (Cocs) for Treatment of Acne Oral Contraceptives in Women with Systemic Lupus Erythematosus Risk of Venous Thrombosis in Users of 3rd Vs. 2nd Generation Combined Oral Contraceptives Biphasic Versus Triphasic Oral Contraceptives for Contraception Hormonal Contraception in Overweight or Obese Women Progestogens in Combined Oral Contraceptives Triphasic Versus Monophasic Oral Contraceptives for Contraception
Norethindrone acetate Biphasic Versus Monophasic Oral Contraceptives Hormonal Contraception in Overweight or Obese Women Combined Oral Contraceptive Pills (Cocs) for Treatment of Acne Risk of Venous Thrombosis in Users of 3rd Vs. 2nd Generation Combined Oral Contraceptives
Norethisterone
Norfloxacin Antibiotics for Acute Bacterial Conjunctivitis Antibiotic Therapy for Shigella Dysentery Oral Treatment for Symptomatic Severe Urinary Tract Infections in Non-Elderly Trimethoprim or Trimethoprim-Sulfamethoxazole and Risk of Hyperkalaemia Among Patients Taking Renin-Angiotensin System Blockers Antibiotics for Preventing Recurrent Urinary Tract Infection (Uti) in Non-Pregnant Women Different Quinolones for Uncomplicated Acute Cystitis in Women Treatment Duration of Febrile Urinary Tract Infection Trimethoprim-Sulfamethoxazole and Risk of Sudden Death Among Patients Taking Renin-Angiotensin System Blockers
Norgestimate Combined Oral Contraceptive Pills (Cocs) for Treatment of Acne Risk of Venous Thrombosis in Users of 3rd Vs. 2nd Generation Combined Oral Contraceptives Progestogens in Combined Oral Contraceptives Third Generation Oral Contraceptives and Risk of Venous Thromboembolism